This review highlights dichrostachys cinerea's multi-target therapeutic potential in infections and inflammation, suggesting new avenues for drug discovery.
Dichrostachys cinerea (L.) Wight and Arn., a plant of the Mimosaceae family, is a medicinal plant with multiple uses that is widely distributed in Africa, Australia, India, and Southeast Asia. It has been extensively used in traditional medicine to cure numerous diseases, including infections, inflammatory disorders, pain, respiratory disorders, and reproductive health disorders. Phytochemical analysis confirmed the existence of several biologically active compounds such as flavonoids, polyphenols, alkaloids, saponins, terpenoids, and tannins playing an extensive role in its therapeutic uses. Its traditional use is also supported by laboratory scientific evidence of antimicrobial, anti-inflammatory, antioxidant, bronchodilatory, diuretic, analgesic, and anti-plasmodial activities. Its protein farnesyltransferase inhibitory effect and possible anticancer activity of the new generation suggest a prospect for its anticancer activity, and uterotonic activity may support the induction of labor. Although it is widely applied, more scientific work on the enhancement of the extraction process, pharmacokinetics, and compounds with bioactive properties is necessary for drug discovery. Major Findings: This review documents the significance of D. cinerea in uniting ancient medicine with modern pharmacological discovery and its prospects as a multi-target drug agent.
No takes yet. Share an insight, caveat, or question.
Vijayalakshmi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: